Cortechs.ai | Age-dependent cutoffs for pathological brain volume loss
RSNA 2025
Contact
RSNA 2026

Age-dependent cutoffs for pathological brain volume loss

  • Category: Published research

Estimates of age-dependent cutoffs for pathological brain volume loss using SIENA/FSLda longitudinal brain volumetry study in healthy adults

Brain volume loss (BVL) has gained increasing interest for monitoring tissue damage in neurodegenerative diseases including multiple sclerosis (MS). In this longitudinal study, 117 healthy participants (age range 37.3 82.6 years) received at least 2 magnetic resonance imaging examinations. BVL (in %) was determined with the Structural Image Evaluation using Normalisation of Atrophy/FMRIB Software Library and annualized. 2017.

[button]Download[/button]

  • Topic: Published research

More Resources

Cortechs.ai | Age-dependent cutoffs for pathological brain volume loss
  • 3 mins

09/18/2026

What a Head CT Can and Can’t Tell You About a Concussion

For Concussion Awareness Day, learn how quantitative CT analysis can help measure subtle structural changes and support follow-up after traumatic brain injury.

Prostate Cancer Awareness Month
  • 4 mins

09/09/2026

Prostate Cancer Awareness Month: Finding the Cancer That Matters

How quantitative MRI can bring greater clarity to decisions across the prostate cancer journey.

Cortechs.ai | Age-dependent cutoffs for pathological brain volume loss
  • 3 mins

09/01/2026

Quantifying What Matters: Advancing Alzheimer’s Imaging with NeuroQuant®

Explore how quantitative imaging is transforming Alzheimer’s care, from structural volumetrics and amyloid PET to treatment monitoring with NeuroQuant®.

Cortechs.ai | Age-dependent cutoffs for pathological brain volume loss
  • 3 mins

08/19/2026

Brain Metastases Imaging Insights from SNO/ASCO 2026

Explore key insights from SNO/ASCO 2026 on brain metastases imaging, including lesion tracking, volumetric analysis, SRS workflows, and automated segmentation.

Cortechs.ai | Age-dependent cutoffs for pathological brain volume loss
  • 2 mins

08/18/2026

Cortechs.ai Announces FDA Clearance for NeuroQuant® PET: Advancing Molecular Imaging for Cognitive Impairment

NeuroQuant® PET receives FDA 510(k) clearance, advancing quantitative PET imaging for cognitive impairment.

,

Cortechs.ai | Age-dependent cutoffs for pathological brain volume loss
  • 3 mins

08/04/2026

Cortechs.ai Expands European CE Marking Across AI Imaging Platform, Accelerating Global Growth

Cortechs.ai expands EU CE Marking for the latest NeuroQuant®, NeuroQuant® Brain Tumor, and OnQ™ Prostate, advancing global AI imaging innovation

,

View our insights
Scroll to Top